Rare diseases
Investigational molecules
Locations
39 Rue Camille Desmoulins, 94800 Villejuif, France
Everimmune is active in non-small cell lung cancer and renal cell carcinoma, with a focus on advanced solid tumours treated in combination with immunotherapy. Its clinical research includes patients with metastatic disease and tumour settings linked to PD-L1-based chemo-immunotherapy.
The sponsor’s oncology interest is centred on treatment combinations used in difficult-to-treat disease, particularly in patients whose tumour biology is linked to Akkermansia deficiency.
Everimmune runs clinical trials in conditions such as Renal cancer, Non-small cell lung cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
